Antioxidant potential of evening primrose oil administration in hyperlipemic rabbits

Life Sciences

Volumn 65, Issue 5, 1999, Pages 543-555

  De la Cruz, J P ^a   Quintero, L ^a   Galvez, J ^a   Villalobos, M A ^a   Sanchez de la Cuesta F ^a  

^a NONE

Author keywords

Atherosclerosis; Evening primrose oil; Glutathione system; Lipid peroxidation

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; PRIMROSE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERLIPIDEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RABBIT; TISSUE DISTRIBUTION;

ANIMALS; ANTILIPEMIC AGENTS; ANTIOXIDANTS; DIET, ATHEROGENIC; DIETARY FATS, UNSATURATED; FATTY ACIDS, ESSENTIAL; GAMMA-LINOLENIC ACID; GLUTATHIONE; HYPERLIPIDEMIAS; LINOLEIC ACIDS; LIPID PEROXIDATION; MALE; PLANT OILS; RABBITS;

ANIMALIA; OENOTHERA; OENOTHERA BIENNIS; ORYCTOLAGUS CUNICULUS; PRIMULA;

EID: 0033603196     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00275-1     Document Type: Article

References (31)

1. H. M. Sinclair, Lancet 1 381-382 (1956).
2. H. M. Sinclair, Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine, Horrobin D. F. (ed.), 1-20, Wiley-Liss, New York (1990).
3. A. Keys, A Multivariate Analysis of Death and Coronary Heart Disease, Key A. (ed.), Harvard University Press, Cambridge (1980).
4. H. Yung-Sheng, A. Bassam, A. Nassar, Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine, Horrobin D. F. (ed.), 127-144, Wiley-Liss, New York (1990).
5. D. F. Horrobin, Seminars in Thrombosis and Hemostasis 19 129-137 (1993).
6. N. E. Cameron, M. A. Cotter, K. C. Dines, S. Robertson, D. Cox, Br. J. Pharmacol. 10 972-977 (1993).
7. Gamma-Linolenic Acid Multicentre Trial Group, Treatment of Diabetic Neuropathy: A New Approach,. Horrobin D. F. (ed.), 119-130, Churchill Livingstone, Edinburgh (1990).
8. G. A. Jamal, Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine, Horrobin D. F. (ed.), 487-504, Wiley-Liss, New York (1990).
9. R. R. Brenner, Lipid Res. 20 41-47 (1981).
10. Y. S. Huang, M. S. Manku, D. F. Horrobin, Lipids 19 664-673 (1984).
11. M. Sugano, T. Ide, T. Ishida, K. Yoshida, Ann. Nutr. Metab. 30 289-299 (1986).
12. J.L. Witztum, Lancet 344 793-795 (1994).
13. S. Krause, A. Pohl, A. Liebrenz, K. Ruhling, W. Losche, Thromb. Res. 71 237-240 (1993).
14. J. P. De La Cruz, T. Carrasco, G. Ortega, F. Sánchez De La Cuesta, Lipids 27 192-194 (1992).
15. O. H. Lowry, N. J. Rosebrough, A. L. Farr, R. J. Randall, J. Biol. Chem 193 265-275 (1951).
16. P. J. Hissin, R. Hill, Anal. Biochem. 74 214-226 (1976).
17. M. M. Bradford, Anal. Biochem. 72 248-254 (1976).
18. L. Flohé, W. A. Gunzler, Meth. Enzymol. 105 114-121 (1984).
19. M. Warholm, C. Guthenberg, C. Von Bahr, B. Mannervik, Meth. Enzymol. 113 499-503 (1985).
20. D. F. Horrobin, Y. S. Huang, Int. J. Cardiol. 17 241-255 (1987).
21. J. P. W. Rivers, T. L. Frankel, Br Med Bull 37 59-64 (1981).
22. Y. Ohara, T. E. Peterson, D. G. Harrison, J. Cin. Invest 91 2546-2551 (1993).
23. E. Tremoli, P. Maderna, M. Sirtori, C. R. Tremoli, Haemostasis 8 47-53 (1979).
24. M. A. Villalobos, J. P. De La Cruz, M. Martin, J. A. Carmona, J. M. Smith, F. Sanchez De La Cuesta, Thrombos Haemostas 80 696-701 (1998).
25. J. P. De La Cruz, M. Martín-Romero, J. A. Carmona, M. A. Villalobos, F. Sánchez De La Cuesta, Thromb. Res. 87 141-149 (1997).
26. M. Warso, W. Lands, Br. Med. Bull. 39 277-280 (1983).
27. M. Navarro, P. Hortelano, J. Periago, M. Pita, Arteriosclerosis and Thrombosis 12 7-12 (1992).
28. M. R. L'Abbe, K. D. Trick, J. L. Beare-Rogers, J. Nutr. 121 1331-1340 (1991).
29. C. T. Hammer, E.D. Wills, Biochem. J. 174 585-593 (1978).
30. B. R. Lokesh, S. M. Mathur, A. A. Spector, J. Lipid Res. 22 905-915 (1981).
31. M. Clement, J. M. Bourre, J. Neurochem. 54 2110-2117 (1990).